<--- Back to Details
First PageDocument Content
Mammalian target of rapamycin / Immunosuppressants / Macrolides / Cell signaling / Sirolimus / AKT / RICTOR / Phosphoinositide 3-kinase / Raptor / Biology / Signal transduction / Protein kinases
Date: 2014-07-15 11:14:25
Mammalian target of rapamycin
Immunosuppressants
Macrolides
Cell signaling
Sirolimus
AKT
RICTOR
Phosphoinositide 3-kinase
Raptor
Biology
Signal transduction
Protein kinases

Store at -20ºC Raptor (24C12) Rabbit mAb www.cellsignal.com

Add to Reading List

Source URL: media.cellsignal.com

Download Document from Source Website

File Size: 265,60 KB

Share Document on Facebook

Similar Documents

EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i

EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i

DocID: 1rhhk - View Document

The brain sirolimus pills. Note: Any medical information published on this computer for up to 3 capsules of Xanax. The brain. To view content sources and attributions, refer to the increase in the past 14 days. Wenn Sie

The brain sirolimus pills. Note: Any medical information published on this computer for up to 3 capsules of Xanax. The brain. To view content sources and attributions, refer to the increase in the past 14 days. Wenn Sie

DocID: 1qxur - View Document

Microsoft Word - 20160704_Opsiria_India

Microsoft Word - 20160704_Opsiria_India

DocID: 1q3TJ - View Document

Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

DocID: 1oXt7 - View Document

Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus]

Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus]

DocID: 1ogX3 - View Document